Filing Flows

Filing Flows › Thermo Fisher Scientific (TMO) › Q2 2026

Thermo Fisher Scientific (TMO) Q2 2026 earnings results (second quarter 2026)

10-Q filed Jul 31, 2026

Thermo Fisher Scientific (TMO) reported revenue of $12.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +9% from the quarter before. Operating margin was 17.4%, net earnings $1.7B (14.5% of revenue).

Revenue$12.0B
Year over year+10%
Quarter over quarter+9%
Operating margin17.4%
Net earnings$1.7B

Thermo Fisher Scientific, Q2 2026: revenue $12.0B (+10% year over year), operating margin 17.4%, net earnings $1.7B, operating cash flow $2.1B. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$12.0B+9%+10%
Operating profit$2.1B+12%+14%
Net earnings$1.7B+5%+8%
Operating cash flow$2.1B+78%+52%
Free cash flow$1.7B+105%+52%

What changed

Revenue was $12.0B in Q2 2026, up 10% year over year and up 9% from the previous quarter. Laboratory Products and Biopharma Services was the largest line at 55% of revenue. Laboratory Products and Biopharma Services added $0.70B year over year (up 12%), 61% of the total change.

Operating profit was $2.1B, a 17.4% margin (up 0.5 points year over year). Of the extra revenue versus Q2 2025, 22% reached operating profit, above the 17% margin then. Total costs grew 10% against revenue growth of 10%. The fastest-growing cost line was Other operating costs (+10%). Net earnings were $1.7B, up 7% year over year. The effective tax rate was 8.8%.

Operating cash flow was $2.1B (up 52% year over year), 122% of net earnings. Non-cash charges added back $0.82B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $0.51B. Capital expenditures of $0.45B left free cash flow of $1.7B.

Questions

What was Thermo Fisher Scientific's revenue in the second quarter 2026?

Thermo Fisher Scientific (TMO) reported revenue of $12.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +9% from the quarter before.

Was Thermo Fisher Scientific profitable in the second quarter 2026?

Operating profit was $2.1B (17.4% of revenue) and net earnings $1.7B.

Open the interactive Sankey →

Source: Thermo Fisher Scientific 10-Q on SEC EDGAR.